Acute Liver Injury after Initiating Atomoxetine in a Girl Patient with ADHD, Autism, and Epilepsy: The First Case Report in Taiwan

發生於一患有注意力不足過動症、自閉症與癲癇兒童病人之Atomoxetine相關肝臟損傷之個案報告

林昌履(Chang-Lu Lin)；張舜傑(Shun-Jie Chang)；林育如(Yu-Ju Lin)

台灣精神醫學

32卷4期（2018 / 12 / 01）

336 - 338

英文

1. Bangs, ME,Jin, L,Zhang, SY(2008).Hepatic events associated with atomoxetine treatment for attentiondeficit hyperactivity disorder.Drug Safety,31,345-354.
2. Erdogan, A,Ozcay, F,Piskin, E(2011).Idiosyncratic liver failure probably associated with atomoxetine: a case report.J Child Adolesc Psychopharmacol,21,295-297.
3. Gau, SS,Huang, YS,Soong, WT(2007).A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder.J Child Adolesc Psychopharmacol,17,447-460.
4. Lim, JR,Faught ,PR,Chalasani, NP,Molleston, JP(2006).Severe liver injury after initiating therapy with atomoxetine in two children.J Pediatr,148,831-834.
5. Reed, VA,Buitelaar, JK,Anand, E(2016).The safety of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of research.CNS Drugs,30,603-628.
6. Ruggiero, S,Rafaniello, C,Bravaccio, C(2012).Safety of attention-deficit/hyperactivity disorder medications in children: An intensive pharmacosurveillance monitoring study.J Child Adolesc Psychopharmacol,22,415-422.
7. Stojanovski, SD,Casavant, MJ,Mousa, HM,Baker, P,Nahata, MC(2007).Atomoxetine-induced hepatitis in a child.Clin Toxicol,45,51-55.
8. The National Institute for Health and Care Excellence(2018).Attention deficit hyperactivity disorder: Diagnosis and management.
9. US FDA(2009).Drug safety newsletter,2,7-9.